Merck
Trade Merck 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRK
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.
MRK Key Statistics
MRK News
In recent days, Merck announced positive Phase 3 results for its CAPVAXIVE® pneumococcal vaccine in children and adolescents, and released encouraging clinical...
Berenberg analyst Luisa Hector downgraded Merck (MRK) to Hold from Buy with a price target of $90, down from $100. The firm says the “error bars” on Merck’s lon...
Health and Human Services Secretary Robert F. Kennedy Jr. has added five new members to the Centers for Disease Control and Prevention’s Advisory Committee on I...
Analyst ratings
56%
of 27 ratingsMore MRK News
experienced a 6% rise in its share price over the last quarter, coinciding with significant developments such as the FDA granting Breakthrough Therapy Designati...
AstraZeneca (AZN) and Eli Lilly (NYSE:LLY) have become the latest leading drugmakers to reconsider their investment options in the U.K. after Merck (MRK) cancel...
Britain’s biggest company AstraZeneca (AZN) has paused a planned $271.26M investment in its Cambridge research site, a spokesperson said, the latest drugmaker t...
Healthcare Merck says trial data for pneumonia shot Capvaxive shows promise in younger people Sep. 11, 2025 7:18 AM ET Merck & Co., Inc. (MRK) Stock By: Dulan L...
Merck (MRK) announced positive results from the Phase 3 STRIDE-13 trial evaluating capvaxive – Pneumococcal 21-valent Conjugate Vaccine – at the 6th European So...